Amgen vs UnitedHealth Group Incorporated at a glance
Both companies operate in the Health Care sector, so these figures are broadly like-for-like.
| Metric | AMGN | UNH |
|---|---|---|
| Market cap | $241.45B | $361.28B |
| Price | $442.24 | $396.59 |
| P/E ratio (TTM) | 22.89 | 24.76 |
| P/B ratio (MRQ) | 20.38 | 3.17 |
| P/S ratio (TTM) | 4.8 | 0.67 |
| Revenue growth (1Y) | 9.92% | 11.81% |
| Return on equity (TTM) | 89.06% | 12.81% |
| Return on invested capital (TTM) | 14.50% | 9.58% |
| Gross margin (TTM) | 72.65% | 22.49% |
| Net margin (TTM) | 22.93% | 3.14% |
| Dividend yield (TTM) | 2.27% | 2.33% |
How they differ
UnitedHealth Group Incorporated is the larger company at $361.28B versus $241.45B — about 1.5x the size.
On trailing earnings, Amgen is the cheaper of the two at 22.89 against 24.76 for UnitedHealth Group Incorporated.
On sales, UnitedHealth Group Incorporated is the cheaper of the two at 0.67 against 4.8 for Amgen.
UnitedHealth Group Incorporated leads on revenue growth over the past year, 11.81% against 9.92%.
Amgen leads on return on invested capital, 14.50% against 9.58%.
Amgen leads on gross margin, 72.65% against 22.49%.
UnitedHealth Group Incorporated offers the higher yield at 2.33% against 2.27%.
Go deeper
Ratios describe the past. Whether either is worth owning depends on what you pay today.
Related comparisons
Other matchups involving Amgen or UnitedHealth Group Incorporated.